Carl H. Cramer

1.3k total citations
17 papers, 432 citations indexed

About

Carl H. Cramer is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Carl H. Cramer has authored 17 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Nephrology. Recurrent topics in Carl H. Cramer's work include Renal Diseases and Glomerulopathies (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Platelet Disorders and Treatments (2 papers). Carl H. Cramer is often cited by papers focused on Renal Diseases and Glomerulopathies (3 papers), Renal Transplantation Outcomes and Treatments (2 papers) and Platelet Disorders and Treatments (2 papers). Carl H. Cramer collaborates with scholars based in United States, Slovakia and France. Carl H. Cramer's co-authors include Richard J. Smith, Nelson Leung, Fernando C. Fervenza, Samih H. Nasr, Sanjeev Sethi, Julie A. Vrana, Carla Nester, Yuzhou Zhang, Dominique Weil and Friedhelm Hildebrandt and has published in prestigious journals such as The American Journal of Human Genetics, The Journal of Urology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Carl H. Cramer

16 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carl H. Cramer United States 9 148 127 114 109 89 17 432
Giuseppina Spartà Switzerland 8 101 0.7× 39 0.3× 96 0.8× 62 0.6× 29 0.3× 14 353
Thomas Barbour Australia 11 382 2.6× 34 0.3× 62 0.5× 530 4.9× 59 0.7× 20 661
Stefania Tamiazzo Italy 9 32 0.2× 32 0.3× 59 0.5× 77 0.7× 26 0.3× 13 405
Tatsu Tanabe Japan 13 59 0.4× 270 2.1× 86 0.8× 57 0.5× 61 0.7× 41 454
Douglas J. Anderson United States 18 23 0.2× 513 4.0× 110 1.0× 116 1.1× 25 0.3× 39 769
Daniel F. Jimenez United States 12 18 0.1× 62 0.5× 228 2.0× 38 0.3× 72 0.8× 14 461
J. Egea Valenzuela Spain 10 18 0.1× 175 1.4× 40 0.4× 34 0.3× 54 0.6× 56 332
Del Kahn South Africa 9 62 0.4× 276 2.2× 62 0.5× 47 0.4× 137 1.5× 11 443
Rosario Nadorra United States 9 80 0.5× 61 0.5× 55 0.5× 49 0.4× 33 0.4× 10 331
Fanny Fouyssac France 11 30 0.2× 14 0.1× 163 1.4× 181 1.7× 43 0.5× 25 430

Countries citing papers authored by Carl H. Cramer

Since Specialization
Citations

This map shows the geographic impact of Carl H. Cramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl H. Cramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl H. Cramer more than expected).

Fields of papers citing papers by Carl H. Cramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl H. Cramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl H. Cramer. The network helps show where Carl H. Cramer may publish in the future.

Co-authorship network of co-authors of Carl H. Cramer

This figure shows the co-authorship network connecting the top 25 collaborators of Carl H. Cramer. A scholar is included among the top collaborators of Carl H. Cramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl H. Cramer. Carl H. Cramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fidler, Mary E., et al.. (2023). Early post-transplant recurrence of ANCA vasculitis while on belatacept maintenance immunosuppression. Journal of Nephrology. 36(4). 1169–1174. 1 indexed citations
2.
Gargollo, Patricio C., Mohamed E. Ahmed, Mikel Prieto, et al.. (2021). Feasibility Study of Vascularized Composite Urinary Bladder Allograft Transplantation in a Cadaver Model. The Journal of Urology. 206(1). 115–123. 8 indexed citations
3.
Neal, James R., et al.. (2020). Using a Modified CPD Blood Bag to Store Blood from either ECMO or RRT Circuit Blood in Pediatric Patients. Journal of ExtraCorporeal Technology. 52(2). 146–150.
4.
Muthusamy, Karthik, Christian Hanna, Derek R. Johnson, et al.. (2020). Growth hormone deficiency in a child with branchio‐oto‐renal spectrum disorder: Clinical evidence of EYA1 in pituitary development and a recommendation for pituitary function surveillance. American Journal of Medical Genetics Part A. 185(1). 261–266. 2 indexed citations
5.
Chua, Annabelle N., Carl H. Cramer, Asha Moudgil, et al.. (2019). Kidney transplant practice patterns and outcome benchmarks over 30 years: The 2018 report of the NAPRTCS. Pediatric Transplantation. 23(8). e13597–e13597. 79 indexed citations
6.
Said, Samar M., Mary E. Fidler, Anthony M. Valeri, et al.. (2016). Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome. Kidney International Reports. 2(1). 44–52. 12 indexed citations
7.
Tran, Cheryl L., Sanjeev Sethi, David Murray, et al.. (2016). Discontinuation of dialysis with eculizumab therapy in a pediatric patient with dense deposit disease. Pediatric Nephrology. 31(4). 683–687. 10 indexed citations
8.
Kittanamongkolchai, Wonngarm, Ziad Zoghby, Russell H. Wiesner, et al.. (2016). Charcoal hemoperfusion in the treatment of medically refractory pruritus in cholestatic liver disease. Hepatology International. 11(4). 384–389. 10 indexed citations
9.
Javed, Asma, Jennifer Leonard, Carl H. Cramer, et al.. (2013). Pseudohypoaldosteronism presenting with thrombocytosis and bilateral pneumothoraces in an infant. Journal of Pediatric Endocrinology and Metabolism. 26(3-4). 393–5. 1 indexed citations
10.
Loar, Robert W., David J. Driscoll, Sudhir S. Kushwaha, et al.. (2013). Empiric switch from calcineurin inhibitor to sirolimus‐based immunosuppression in pediatric heart transplantation recipients. Pediatric Transplantation. 17(8). 794–799. 12 indexed citations
11.
Weaver, Amy L., et al.. (2012). Correlation of Blood Pressure Readings From 6‐Hour Intervals With the Daytime Period of 24‐Hour Ambulatory Blood Pressure Monitoring in Pediatric Patients. Journal of Clinical Hypertension. 14(6). 396–400. 4 indexed citations
12.
Sethi, Sanjeev, Fernando C. Fervenza, Yuzhou Zhang, et al.. (2011). Proliferative Glomerulonephritis Secondary to Dysfunction of the Alternative Pathway of Complement. Clinical Journal of the American Society of Nephrology. 6(5). 1009–1017. 113 indexed citations
13.
Cramer, Carl H., Victoria Shieck, Susan E. Thomas, et al.. (2008). Immune response to rabies vaccination in pediatric transplant patients. Pediatric Transplantation. 12(8). 874–877. 19 indexed citations
14.
Hoskins, Bethan E., Carl H. Cramer, Derek Silvius, et al.. (2007). Transcription Factor SIX5 Is Mutated in Patients with Branchio-Oto-Renal Syndrome. The American Journal of Human Genetics. 80(4). 800–804. 137 indexed citations
15.
Cramer, Carl H., et al.. (2006). Gastrointestinal Symptoms of Henoch‐Schönlein Purpura Treated with Mycophenolate Mofetil. Journal of Pediatric Gastroenterology and Nutrition. 43(2). 245–247. 13 indexed citations
16.
Wellnhofer, Ernst, Carl H. Cramer, Stephan Dreysse, & Eckart Fleck. (2000). Lung water, hemodynamics and dyspnea before and after valvuloplasty in mitral stenosis. International Journal of Cardiology. 75(2-3). 217–225. 4 indexed citations
17.
Cramer, Carl H., et al.. (1951). Friedländer bacillus meningitis in a case with liver abscess and recurrent bacteremia and analysis of cases receiving specific therapy.. PubMed. 51(6). 761–5. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Giuseppina Spartà Breakdown of academic impact, for papers by Thomas Barbour Breakdown of academic impact, for papers by Stefania Tamiazzo Breakdown of academic impact, for papers by Tatsu Tanabe Breakdown of academic impact, for papers by Douglas J. Anderson Breakdown of academic impact, for papers by Daniel F. Jimenez Breakdown of academic impact, for papers by J. Egea Valenzuela Breakdown of academic impact, for papers by Del Kahn Breakdown of academic impact, for papers by Rosario Nadorra Breakdown of academic impact, for papers by Fanny Fouyssac
Rankless by CCL
2026